SE0202886D0 - Dermatological use and a dermatological preparation - Google Patents

Dermatological use and a dermatological preparation

Info

Publication number
SE0202886D0
SE0202886D0 SE0202886A SE0202886A SE0202886D0 SE 0202886 D0 SE0202886 D0 SE 0202886D0 SE 0202886 A SE0202886 A SE 0202886A SE 0202886 A SE0202886 A SE 0202886A SE 0202886 D0 SE0202886 D0 SE 0202886D0
Authority
SE
Sweden
Prior art keywords
dermatological
preparation
triiodothyronine
thyroxine
thyroid hormone
Prior art date
Application number
SE0202886A
Other languages
English (en)
Other versions
SE0202886L (sv
Inventor
Pekka Heino
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of SE0202886D0 publication Critical patent/SE0202886D0/sv
Publication of SE0202886L publication Critical patent/SE0202886L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
SE0202886A 2000-04-06 2002-10-01 Dermatologisk användning och dermatologisk beredning SE0202886L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000818A FI107018B (sv) 2000-04-06 2000-04-06 Dermatologisk användning och dermatologiskt preparat
PCT/FI2001/000100 WO2001076589A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation

Publications (2)

Publication Number Publication Date
SE0202886D0 true SE0202886D0 (sv) 2002-10-01
SE0202886L SE0202886L (sv) 2002-12-02

Family

ID=8558139

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202886A SE0202886L (sv) 2000-04-06 2002-10-01 Dermatologisk användning och dermatologisk beredning

Country Status (14)

Country Link
US (2) US20030144359A1 (sv)
EP (1) EP1274416A1 (sv)
JP (1) JP2003530349A (sv)
AU (1) AU2001235506A1 (sv)
CA (1) CA2405425A1 (sv)
CH (1) CH695983A5 (sv)
DE (1) DE10196025T1 (sv)
DK (1) DK200201483A (sv)
ES (1) ES2193003B1 (sv)
FI (1) FI107018B (sv)
GB (1) GB2377380B (sv)
NO (1) NO20024810L (sv)
SE (1) SE0202886L (sv)
WO (1) WO2001076589A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0831769B2 (en) * 1995-06-07 2008-07-23 Lavin, Dr., Thomas N. Novel uses for thyroid hormones or thyroid hormone-like compounds
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
EP2335694B1 (en) * 2003-09-15 2018-06-13 NanoPharmaceuticals LLC Thyroid hormone analogs and methods of use
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
US9220788B2 (en) 2009-06-17 2015-12-29 Nanopharmaceuticals Llc Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
WO2007035612A2 (en) 2005-09-16 2007-03-29 Ordway Research Institute, Inc. Polyphenol conjugates as rgd-binding compounds and methods of use
AU2007353426A1 (en) 2006-12-22 2008-11-20 Albany College Of Pharmacy And Health Sciences Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
US20100159021A1 (en) * 2008-12-23 2010-06-24 Paul Davis Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use
WO2010120506A1 (en) 2009-03-31 2010-10-21 Ordway Research Institute, Inc. Combination treatment of cancer with cetuximab and tetrac
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
WO2017214299A1 (en) 2016-06-07 2017-12-14 Nanopharmaceuticals, Llc NON-CLEAVABLE POLYMER CONJUGATED WITH αvβ3 INTEGRIN THYROID ANTAGONISTS
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859546A (en) * 1956-05-29 1961-01-25 Arthur Alfred Hellbaum Composition for treatment of the skin
US3198702A (en) * 1960-03-17 1965-08-03 Arthur A Hellbaum Method for treating skin burns
AU1843295A (en) * 1994-02-23 1995-09-11 Chiron Corporation Method and compositions for increasing the serum half-life of pharmacologically active agents
EP0831769B2 (en) * 1995-06-07 2008-07-23 Lavin, Dr., Thomas N. Novel uses for thyroid hormones or thyroid hormone-like compounds
US6380255B1 (en) * 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
JP2002542284A (ja) * 1999-04-26 2002-12-10 ダンフォース，エリオット，ジュニア テトラックの薬学組成物およびその使用方法
US6716877B2 (en) * 2001-01-31 2004-04-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels

Also Published As

Publication number Publication date
ES2193003A1 (es) 2003-10-16
CA2405425A1 (en) 2001-10-18
US20030144359A1 (en) 2003-07-31
EP1274416A1 (en) 2003-01-15
SE0202886L (sv) 2002-12-02
NO20024810D0 (no) 2002-10-04
GB2377380B (en) 2004-07-14
GB2377380A (en) 2003-01-15
DE10196025T1 (de) 2003-03-13
ES2193003B1 (es) 2005-02-01
DK200201483A (da) 2002-10-03
FI20000818A0 (sv) 2000-04-06
US20050272817A1 (en) 2005-12-08
CH695983A5 (de) 2006-11-15
NO20024810L (no) 2002-12-06
WO2001076589A1 (en) 2001-10-18
AU2001235506A1 (en) 2001-10-23
GB0222880D0 (en) 2002-11-13
FI107018B (sv) 2001-05-31
JP2003530349A (ja) 2003-10-14

Similar Documents

Publication Publication Date Title
SE0202886D0 (sv) Dermatological use and a dermatological preparation
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
NO20020299D0 (no) Behandling og sammensetning for oppnåelse av antialdring av hud med Corneum Protease aktivering
GB0105772D0 (en) Use
MXPA05004404A (es) Composicion topica para cuidado de la piel.
EA200100934A1 (ru) Применение ингибиторов cyp2d6 в комбинированных способах лечения
ATE429947T1 (de) Vorrichtung zur topischen verabreichung
ATE312635T1 (de) Ventilanordnung
ES2192227T3 (es) Composiciones farmaceuticas orales con liberacion retardada de inhibidores reversibles de las bombas de protones.
ID27503A (id) Tts yang mengandung antioksidan
NO20052494D0 (no) Preparater inneholdende melatonin, gingko biloba og biotin.
IL160523A0 (en) PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
ATE339224T1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
UY26474A1 (es) Inhibidores de aminotransferasa dependiente de aminoácidos de cadena ramificada, y su uso en el tratamiento de la retinopatía diabética.
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
IS2147B (is) Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju
ATE324112T1 (de) Topische behandlung bei der mastalgie
DK0994704T3 (da) Anvendelse af GABA-analoger såsom gabapentin i fremstillingen af et medikament til behandling af inflammatoriske sygdomme
MY111718A (en) Deuterated active substances in transdermal application
DK1220678T3 (da) Farmaceutiske præparater indeholdende kobber, salicylsyre og C-vitamin
CR8584A (es) Piperazinas derivadas de urea para el tratamiento de la endometrosis
TR199901206T2 (xx) Diyabetik damar rahats�zl�klar�n�n �nlenmesi i�in bir ila� �retiminde katekol-O-metil transferaz inhibit�rlerinin kullan�lmas�.
DE69904735T2 (de) Schweisshemmendes produkt und methode
SE0300535D0 (sv) Treatment of burns
BRPI0509305A (pt) uso de um sensibilizador insulìnico, composição farmecêutica, e , kit

Legal Events

Date Code Title Description
NAV Patent application has lapsed